Why stimulants are driving the crisis

Stimulants like methamphetamine and cocaine have become increasingly accessible and potent, contributing to higher rates of overdose and severe health complications. Unlike opioids, which often cause respiratory depression, stimulant overdoses frequently lead to cardiovascular events, psychosis, and

Australia faces surge in stimulant driven drug deaths and hospitalizations

Australia is experiencing a sharp rise in drug related deaths and hospitalizations, primarily driven by amphetamine type stimulants and cocaine. The National Drug and Alcohol Research Center at UNSW Sydney reports over 2,000 overdose deaths in 2024, equating to 5.5 deaths daily. Hospitalizations surged by 10.5% in 2023 24, with nearly 57,000 cases recorded. The data underscores growing public health concerns about stimulant misuse and its consequences.

The National Drug and Alcohol Research Center (NDARC) at UNSW Sydney has released alarming new figures on drug related harms in Australia. In 2024, the country recorded more than 2,000 drug induced deaths, averaging 5.5 fatalities per day. This follows a 10.5% increase in drug related hospitalizations during 2023 24, with nearly 57,000 cases, or 156 admissions daily.

The rise is largely attributed to amphetamine type stimulants and cocaine, which have overtaken opioids as the primary drivers of drug related harm. While opioid related deaths remain a concern, the shift toward stimulants marks a troubling trend in Australia's drug landscape.